The FDA on Monday approved a new, easy-to-use version of a medication to reverse...
With more effective treatments available, a study finds that screening all Ameri...
As Seagen prepares to be acquired by Pfizer, an investor advisory firm is raisin...
Adding an oral option of Ozempic and Wegovy would give Novo Nordisk “the first s...
A FDA advisory panel voted against approving an investigational treatment from I...
The well-intended "screen and refer" system is not only ineffective but also deh...
Vyjuvek is claimed to be the first and only FDA-approved treatment for both rece...
Up to £24m will be used to strengthen the UK’s collaboration with CARB-X.
The new facility will offer end-to-end pharmaceutical development and manufactur...
Epkinly’s approval was supported by the findings from the Phase I/II EPCORE NHL-...
In the latest update of the ongoing Covid-19 mRNA vaccine dispute, CureVac has s...
Following a year of HRT shortages in 2022, the UK is issuing a serious shortage ...
This marks another setback for Ocaliva in this indication, as the race towards t...
SinoMab BioScience intends to commence a Phase I clinical trial in China to eval...
Ironwood expects the deal to strengthen its portfolio and pipeline to advance th...
In the second edition of Money Moves, we look at how European funding could help...
